International Stem Cell (ISCO) Accumulated Depreciation & Amortization (2016 - 2025)
International Stem Cell (ISCO) has disclosed Accumulated Depreciation & Amortization for 14 consecutive years, with $36000.0 as the latest value for Q3 2025.
- On a quarterly basis, Accumulated Depreciation & Amortization rose 9.09% to $36000.0 in Q3 2025 year-over-year; TTM through Sep 2025 was $36000.0, a 9.09% increase, with the full-year FY2024 number at $124000.0, up 10.71% from a year prior.
- Accumulated Depreciation & Amortization was $36000.0 for Q3 2025 at International Stem Cell, up from $34000.0 in the prior quarter.
- In the past five years, Accumulated Depreciation & Amortization ranged from a high of $171000.0 in Q4 2021 to a low of $27000.0 in Q2 2023.
- A 5-year average of $62947.4 and a median of $37000.0 in 2022 define the central range for Accumulated Depreciation & Amortization.
- Peak YoY movement for Accumulated Depreciation & Amortization: surged 158.54% in 2022, then crashed 74.53% in 2023.
- International Stem Cell's Accumulated Depreciation & Amortization stood at $171000.0 in 2021, then fell by 19.88% to $137000.0 in 2022, then dropped by 18.25% to $112000.0 in 2023, then rose by 10.71% to $124000.0 in 2024, then tumbled by 70.97% to $36000.0 in 2025.
- Per Business Quant, the three most recent readings for ISCO's Accumulated Depreciation & Amortization are $36000.0 (Q3 2025), $34000.0 (Q2 2025), and $35000.0 (Q1 2025).